Global Cardiopulmonary Autotransfusion System Competitive Landscape Professional Research Report 2024

Report Format: PDF   |   Report ID: 5680300   |   Published Date: August 2024   |   Pages:  170+  

Research Summary
A cardiopulmonary autotransfusion system, also known as a cell saver or intraoperative blood salvage system, is a medical device used during surgical procedures to collect and process a patient's own blood for reinfusion. The system works by capturing and filtering blood lost during surgery, such as from the operative field or during cardiopulmonary bypass, and returning it back to the patient. The collected blood is processed to remove any contaminants, including debris and anticoagulants, and then reinfused to replenish the patient's blood volume. By utilizing the patient's own blood, cardiopulmonary autotransfusion reduces or eliminates the need for donor blood transfusions, minimizing the risks associated with transfusion reactions and transmission of infections. It is commonly used in cardiac surgery, orthopedic procedures, and other surgeries where significant blood loss is anticipated. Cardiopulmonary autotransfusion systems contribute to improved patient outcomes, reduced need for allogeneic blood transfusions, and cost savings in the healthcare setting.
According to DIResearch's in-depth investigation and research, the global Cardiopulmonary Autotransfusion System market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Cardiopulmonary Autotransfusion System include Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Cardiopulmonary Autotransfusion System. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Cardiopulmonary Autotransfusion System market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Cardiopulmonary Autotransfusion System market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Cardiopulmonary Autotransfusion System industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy. ?  ? 
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Cardiopulmonary Autotransfusion System Include:
Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources
Cardiopulmonary Autotransfusion System Product Segment Include:
Intraoperative Autotransfusion Systems
Postoperative Autotransfusion Systems
Cardiopulmonary Autotransfusion System Product Application Include:
Cardiac Surgeries
Orthopedic Surgeries
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Cardiopulmonary Autotransfusion System Industry PESTEL Analysis
Chapter 3: Global Cardiopulmonary Autotransfusion System Industry Porter's Five Forces Analysis
Chapter 4: Global Cardiopulmonary Autotransfusion System Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Cardiopulmonary Autotransfusion System Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Cardiopulmonary Autotransfusion System Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Cardiopulmonary Autotransfusion System Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Cardiopulmonary Autotransfusion System Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Cardiopulmonary Autotransfusion System Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Cardiopulmonary Autotransfusion System Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Cardiopulmonary Autotransfusion System Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Cardiopulmonary Autotransfusion System Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents

1 Cardiopulmonary Autotransfusion System Market Overview

1.1 Product Definition and Statistical Scope

1.2 Cardiopulmonary Autotransfusion System Product by Type

1.2.1 Global Cardiopulmonary Autotransfusion System Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Intraoperative Autotransfusion Systems

1.2.3 Postoperative Autotransfusion Systems

1.3 Cardiopulmonary Autotransfusion System Product by Application

1.3.1 Global Cardiopulmonary Autotransfusion System Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Cardiac Surgeries

1.3.3 Orthopedic Surgeries

1.3.4 Other

1.4 Global Cardiopulmonary Autotransfusion System Market Revenue and Sales Analysis

1.4.1 Global Cardiopulmonary Autotransfusion System Market Size Analysis (2019-2030)

1.4.2 Global Cardiopulmonary Autotransfusion System Market Sales Analysis (2019-2030)

1.4.3 Global Cardiopulmonary Autotransfusion System Market Sales Price Trend Analysis (2019-2030)

1.5 Cardiopulmonary Autotransfusion System Market Development Status and Trends

1.5.1 Cardiopulmonary Autotransfusion System Industry Development Status Analysis

1.5.2 Cardiopulmonary Autotransfusion System Industry Development Trends Analysis

2 Cardiopulmonary Autotransfusion System Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Cardiopulmonary Autotransfusion System Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Cardiopulmonary Autotransfusion System Market Analysis by Regions

4.1 Cardiopulmonary Autotransfusion System Overall Market: 2023 VS 2024 VS 2030

4.2 Global Cardiopulmonary Autotransfusion System Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Cardiopulmonary Autotransfusion System Revenue and Market Share by Region (2019-2024)

4.2.2 Global Cardiopulmonary Autotransfusion System Revenue Forecast by Region (2025-2030)

4.3 Global Cardiopulmonary Autotransfusion System Sales and Forecast Analysis (2019-2030)

4.3.1 Global Cardiopulmonary Autotransfusion System Sales and Market Share by Region (2019-2024)

4.3.2 Global Cardiopulmonary Autotransfusion System Sales Forecast by Region (2025-2030)

4.4 Global Cardiopulmonary Autotransfusion System Sales Price Trend Analysis (2019-2030)

5 Global Cardiopulmonary Autotransfusion System Market Size by Type and Application

5.1 Global Cardiopulmonary Autotransfusion System Market Size by Type

5.1.1 Global Cardiopulmonary Autotransfusion System Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Cardiopulmonary Autotransfusion System Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Cardiopulmonary Autotransfusion System Market Size by Application

5.2.1 Global Cardiopulmonary Autotransfusion System Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Cardiopulmonary Autotransfusion System Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Cardiopulmonary Autotransfusion System Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Cardiopulmonary Autotransfusion System Market Size by Type

6.3.1 North America Cardiopulmonary Autotransfusion System Sales by Type (2019-2030)

6.3.2 North America Cardiopulmonary Autotransfusion System Revenue by Type (2019-2030)

6.4 North America Cardiopulmonary Autotransfusion System Market Size by Application

6.4.1 North America Cardiopulmonary Autotransfusion System Sales by Application (2019-2030)

6.4.2 North America Cardiopulmonary Autotransfusion System Revenue by Application (2019-2030)

6.5 North America Cardiopulmonary Autotransfusion System Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Cardiopulmonary Autotransfusion System Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Cardiopulmonary Autotransfusion System Market Size by Type

7.3.1 Europe Cardiopulmonary Autotransfusion System Sales by Type (2019-2030)

7.3.2 Europe Cardiopulmonary Autotransfusion System Revenue by Type (2019-2030)

7.4 Europe Cardiopulmonary Autotransfusion System Market Size by Application

7.4.1 Europe Cardiopulmonary Autotransfusion System Sales by Application (2019-2030)

7.4.2 ? Europe Cardiopulmonary Autotransfusion System Revenue by Application (2019-2030)

7.5 Europe Cardiopulmonary Autotransfusion System Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Cardiopulmonary Autotransfusion System Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Cardiopulmonary Autotransfusion System Market Size by Type

8.3.1 China Cardiopulmonary Autotransfusion System Sales by Type (2019-2030)

8.3.2 China Cardiopulmonary Autotransfusion System Revenue by Type (2019-2030)

8.4 China Cardiopulmonary Autotransfusion System Market Size by Application

8.4.1 China Cardiopulmonary Autotransfusion System Sales by Application (2019-2030)

8.4.2 China Cardiopulmonary Autotransfusion System Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Cardiopulmonary Autotransfusion System Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Cardiopulmonary Autotransfusion System Market Size by Type

9.3.1 APAC (excl. China) Cardiopulmonary Autotransfusion System Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Cardiopulmonary Autotransfusion System Revenue by Type (2019-2030)

9.4 APAC (excl. China) Cardiopulmonary Autotransfusion System Market Size by Application

9.4.1 APAC (excl. China) Cardiopulmonary Autotransfusion System Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Cardiopulmonary Autotransfusion System Revenue by Application (2019-2030)

9.5 APAC (excl. China) Cardiopulmonary Autotransfusion System Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Cardiopulmonary Autotransfusion System Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Cardiopulmonary Autotransfusion System Market Size by Type

10.3.1 Latin America Cardiopulmonary Autotransfusion System Sales by Type (2019-2030)

10.3.2 Latin America Cardiopulmonary Autotransfusion System Revenue by Type (2019-2030)

10.4 Latin America Cardiopulmonary Autotransfusion System Market Size by Application

10.4.1 Latin America Cardiopulmonary Autotransfusion System Sales by Application (2019-2030)

10.4.2 Latin America Cardiopulmonary Autotransfusion System Revenue by Application (2019-2030)

10.5 Latin America Cardiopulmonary Autotransfusion System Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Cardiopulmonary Autotransfusion System Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Cardiopulmonary Autotransfusion System Market Size by Type

11.3.1 Middle East & Africa Cardiopulmonary Autotransfusion System Sales by Type (2019-2030)

11.3.2 Middle East & Africa Cardiopulmonary Autotransfusion System Revenue by Type (2019-2030)

11.4 Middle East & Africa Cardiopulmonary Autotransfusion System Market Size by Application

11.4.1 Middle East & Africa Cardiopulmonary Autotransfusion System Sales by Application (2019-2030)

11.4.2 Middle East & Africa Cardiopulmonary Autotransfusion System Revenue by Application (2019-2030)

11.5 Middle East & Africa Cardiopulmonary Autotransfusion System Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Cardiopulmonary Autotransfusion System Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Cardiopulmonary Autotransfusion System Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Cardiopulmonary Autotransfusion System Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Cardiopulmonary Autotransfusion System Average Sales Price by Manufacturers (2020-2024)

12.2 Cardiopulmonary Autotransfusion System Competitive Landscape Analysis and Market Dynamic

12.2.1 Cardiopulmonary Autotransfusion System Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Haemonetics

13.1.1 Haemonetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Haemonetics Cardiopulmonary Autotransfusion System Product Portfolio

13.1.3 Haemonetics Cardiopulmonary Autotransfusion System Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Medtronic

13.2.1 Medtronic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Medtronic Cardiopulmonary Autotransfusion System Product Portfolio

13.2.3 Medtronic Cardiopulmonary Autotransfusion System Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 LivaNova

13.3.1 LivaNova Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 LivaNova Cardiopulmonary Autotransfusion System Product Portfolio

13.3.3 LivaNova Cardiopulmonary Autotransfusion System Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Fresenius Kabi

13.4.1 Fresenius Kabi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Fresenius Kabi Cardiopulmonary Autotransfusion System Product Portfolio

13.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Terumo

13.5.1 Terumo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Terumo Cardiopulmonary Autotransfusion System Product Portfolio

13.5.3 Terumo Cardiopulmonary Autotransfusion System Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Wandong Health Sources

13.6.1 Wandong Health Sources Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Wandong Health Sources Cardiopulmonary Autotransfusion System Product Portfolio

13.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Cardiopulmonary Autotransfusion System Industry Chain Analysis

14.2 Cardiopulmonary Autotransfusion System Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Cardiopulmonary Autotransfusion System Typical Downstream Customers

14.4 Cardiopulmonary Autotransfusion System Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: DIResearch
Choose License

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support